Efficient Blockade of Akt signaling is a determinant factor to overcome resistance to Matuzumab
Débora Dummer Meira(Instituto Nacional de Câncer - INCA), Carlos Gil Ferreira(Instituto Nacional do Câncer)
Cited by 10
Related Papers
Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells
|British Journal of Cancer|2009|50